---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-22-000018"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2022-07-21T23:59:59+00:00"
generated_at: "2026-06-24T09:57:49.007170+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience extends merger Outside Date with Emerald Health to Oct 15, 2022; adjusts meeting timeline for SEC review

## Summary
- Outside Date extended to October 15, 2022; auto-extends to Nov 15 if SEC reviews proxy statement.
- Shareholder meeting must be held by Oct 4 (no SEC review), Nov 4 (SEC review), or Nov 14 (amendments required).
- Second amendment to Arrangement Agreement dated May 11, 2022; parties may further extend Outside Date by 45 days.
- Extension conditioned on satisfaction of certain closing conditions and regulatory approvals not yet obtained.

## SEC filing metadata
- accession: 0001516551-22-000018
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2022-07-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655122000018/0001516551-22-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655122000018/skye-20220715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-22-000018
- JSON: https://secwatch.observer/filing/0001516551-22-000018.json
- Plain text: https://secwatch.observer/filing/0001516551-22-000018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.